209 related articles for article (PubMed ID: 18632508)
21. [Mantle cell lymphoma: an overview from diagnosis to future therapies].
Le Gouill S
Rev Med Interne; 2010 Sep; 31(9):615-20. PubMed ID: 20488592
[TBL] [Abstract][Full Text] [Related]
22. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
23. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
Geisler CH; Kolstad A; Laurell A; Jerkeman M; Räty R; Andersen NS; Pedersen LB; Eriksson M; Nordström M; Kimby E; Bentzen H; Kuittinen O; Lauritzsen GF; Nilsson-Ehle H; Ralfkiaer E; Ehinger M; Sundström C; Delabie J; Karjalainen-Lindsberg ML; Brown P; Elonen E;
Br J Haematol; 2012 Aug; 158(3):355-62. PubMed ID: 22640180
[TBL] [Abstract][Full Text] [Related]
24. Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?
Sweetenham JW
Bone Marrow Transplant; 2001 Nov; 28(9):813-20. PubMed ID: 11781640
[TBL] [Abstract][Full Text] [Related]
25. Mantle cell lymphoma: state of the art.
Skarbnik AP; Goy AH
Clin Adv Hematol Oncol; 2015 Jan; 13(1):44-55. PubMed ID: 25679973
[TBL] [Abstract][Full Text] [Related]
26. CD5 negative mantle cell lymphoma: a different clinical entity?
Alvarez-Argote J; Bauer FA; Dasanu CA
Conn Med; 2014 Apr; 78(4):211-4. PubMed ID: 24830117
[TBL] [Abstract][Full Text] [Related]
27. Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.
Oertel J; Kingreen D; Busemann C; Stein H; Dörken B
J Cancer Res Clin Oncol; 2002 Apr; 128(4):182-8. PubMed ID: 11935308
[TBL] [Abstract][Full Text] [Related]
28. Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma.
Kodama T; Ohshima K; Nomura K; Taniwaki M; Nakamura N; Nakamura S; Kohno S; Yamamoto J; Karube K; Yamasita Y; Shirakusa T; Kikuchi M
Histopathology; 2005 Nov; 47(5):467-78. PubMed ID: 16241994
[TBL] [Abstract][Full Text] [Related]
29. [Composite lymphoma cosisting of mantle cell lymphoma and follicular lymphoma].
Matsuoka A; Tsushima T; Tanibuchi M; Katsuki N; Kushida Y; Takata K; Taoka T
Rinsho Ketsueki; 2013 Nov; 54(11):2056-61. PubMed ID: 24305539
[TBL] [Abstract][Full Text] [Related]
30. Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.
Dietrich S; Tielesch B; Rieger M; Nickelsen M; Pott C; Witzens-Harig M; Kneba M; Schmitz N; Ho AD; Dreger P
Cancer; 2011 May; 117(9):1901-10. PubMed ID: 21509767
[TBL] [Abstract][Full Text] [Related]
31. [Longterm indolent course of pleomorphic mantle cell lymphoma with multiple chromosomal abnormalities].
Pazur M; Ostojić A; Jelić-Puskarić B; Kardum-Skelin I; Vrhovac R; Gasparov S; Trcić RL; Jaksić B
Acta Med Croatica; 2011 Sep; 65 Suppl 1():197-201. PubMed ID: 23126052
[TBL] [Abstract][Full Text] [Related]
32. [Mantle cell lymphoma].
Khosravi Shahi P; Del Castillo Rueda A; Pérez Manga G
An Med Interna; 2007 Mar; 24(3):142-5. PubMed ID: 17590138
[TBL] [Abstract][Full Text] [Related]
33. Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop.
Williams ME; Dreyling MH; Kahl BS; Leonard JP; O'Connor OA; Press OW; Wilson WH
Leuk Lymphoma; 2010 Mar; 51(3):390-8. PubMed ID: 20038219
[TBL] [Abstract][Full Text] [Related]
34. Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
Metzner B; Müller TH; Gebauer W; Casper J; Kraemer D; Rosien B; Schumann-Binarsch S; Thole R; Köhne CH; Dreyling M; Hoster E; Pott C
Ann Hematol; 2014 May; 93(5):803-10. PubMed ID: 24337447
[TBL] [Abstract][Full Text] [Related]
35. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
[TBL] [Abstract][Full Text] [Related]
37. Mantle cell lymphoma of the rectum at an early stage: a case report.
Terauchi S; Yamamoto K; Fujii H; Koyama F; Sugimori S; Enomoto H; Yamanouchi M; Nakano H
Hepatogastroenterology; 2001; 48(39):675-7. PubMed ID: 11462900
[TBL] [Abstract][Full Text] [Related]
38. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
Joao C; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Markovic SN
Bone Marrow Transplant; 2006 May; 37(9):865-71. PubMed ID: 16532015
[TBL] [Abstract][Full Text] [Related]
39. Mantle cell lymphoma: established therapeutic options and future directions.
Lenz G; Dreyling M; Hiddemann W
Ann Hematol; 2004 Feb; 83(2):71-7. PubMed ID: 14669040
[TBL] [Abstract][Full Text] [Related]
40. Treatment strategies in mantle cell lymphoma.
Maddocks K; Blum KA
Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]